HERTFORDSHIRE, England and PITTSBURGH, Nov. 9, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ, TASE: MYL) today announced its financial results for the quarter and nine months ended September 30, 2016.
Third Quarter 2016 Financial Highlights
Total revenues and adjusted total revenues of $3.06 billion, each up 13% compared to the prior year period predominantly due to net sales from acquisitions and new product launches
Generics segment third party net sales of $2.61 billion, up 17% (up 16% on an adjusted basis) compared to the prior year period
Specialty segment third party net sales of $418.7 million, down 4% compared to the prior year period
